Old Web
English
Sign In
Acemap
>
authorDetail
>
Deirdre Jill Cohen
Deirdre Jill Cohen
Icahn School of Medicine at Mount Sinai
Internal medicine
Medicine
Oncology
DNA mismatch repair
Cell
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pre-screening as a tool for increasing oncology trial enrollment.
2021
Journal of Clinical Oncology
Jennifer Wu
Amin Yakubov
Mohammad Maher Abdul Hay
Erica Love
Gianna Kroening
Deirdre Jill Cohen
Christy Spalink
Ankeeta Joshi
Arjun Vasant Balar
Kathie-Ann Joseph
Joseph Ravenell
Janice M. Mehnert
Show All
Source
Cite
Save
Citations (0)
Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC)—NRG-GI004/SWOG-S1610.
2021
Journal of Clinical Oncology
Michael J. Overman
Greg Yothers
Samuel A. Jacobs
Hanna K. Sanoff
Deirdre Jill Cohen
Katherine A. Guthrie
Norah Lynn Henry
Patricia A. Ganz
Scott Kopetz
Peter C. Lucas
Charles D. Blanke
Norman Wolmark
Howard S. Hochster
Thomas J. George
Caio Max Sao Pedro Rocha Lima
Show All
Source
Cite
Save
Citations (2)
1